CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Halozyme Therapeutics, Inc. Company Snapshot
Halozyme Therapeutics, Inc. operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Halozyme Therapeutics with three other companies in this sector in the United States: Heska Corporation (2015 sales of $104.60 million of which 81% was Core Companion Animal Health), Ariad Pharmaceuticals Incorporated ($118.80 million of which 100% was Research Revenue), and Momenta Pharmaceuticals, Inc. ($89.65 million of which 100% was Drug Products).

Sales Analysis. During the year ended December of 2015, sales at Halozyme Therapeutics were $135.06 million. This is an increase of 79.3% versus 2014, when the company's sales were $75.33 million. This was the third consecutive year of growth at Halozyme Therapeutics.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Halozyme Therapeutics, Inc.
  Stock Performance Chart for Halozyme Therapeutics, Inc.
 
  Stock Data: Recent Stock Performance:
  Current Price (9/23/2016): 12.09
(Figures in U.S. Dollars)
1 Week 0.9%   13 Weeks 23.1%  
4 Weeks 43.2%   52 Weeks -24.5%  
 
Halozyme Therapeutics, Inc. Key Data:
  Ticker: HALO Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2015 Sales 135,057,000
(Year Ending Jan 2016).
Employees: 153
  Currency: U.S. Dollars Market Cap: 1,564,616,227
  Fiscal Yr Ends: December Shares Outstanding: 129,414,080
  Share Type: Common Closely Held Shares: 20,777,477
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.